HCV patients have reduced levels of adiponectin and leptin, and increased levels of resistin, ghrelin and vizfatin, contributing to inflammation, insulin resistance, lipid disorders and atherosclerosis and consequently to the development of hypertension and obesity [8,21,22]. Here, ADIPOQ is linked to obesity disorder.